Elevance Health (ELV) Capital Expenditures (2010 - 2026)

Elevance Health (ELV) has 17 years of Capital Expenditures data on file, last reported at $235.0 million in Q1 2026.

• Capital Expenditures for Q1 2026 came in at $235.0 million, up 19.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 billion (down 1.53% YoY), and the FY2025 annual result was $1.1 billion, down 11.15% from the prior year.
• Capital Expenditures declined to $235.0 million in Q1 2026 per ELV's latest filing, from $293.0 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $360.0 million in Q3 2025 and troughed at $196.0 million in Q1 2025.
• A 5-year average of $297.4 million and a median of $301.0 million in 2023 frame the typical range for Capital Expenditures.
• The sharpest annual moves came in 2022 and 2025: Capital Expenditures rose 24.51% in 2022, then slipped 29.75% in 2025.
• A 5-year view of Capital Expenditures shows it stood at $298.0 million in 2022, then advanced by 9.4% to $326.0 million in 2023, then fell by 1.23% to $322.0 million in 2024, then dropped by 9.01% to $293.0 million in 2025, then slipped by 19.8% to $235.0 million in 2026.
• Business Quant data shows ELV's Capital Expenditures at $235.0 million in Q1 2026, $293.0 million in Q4 2025, and $360.0 million in Q3 2025.